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Transcription of transposable elements is tightly regulated to prevent genome damage. KRAB 
domain-containing zinc finger proteins (KRAB-ZFPs) and KRAB-associated protein 1 
(KAP1/TRIM28) play a key role in regulating retrotransposons. KRAB-ZFPs recognize specific 15	
retrotransposon sequences and recruit KAP1, inducing the assembly of an epigenetic silencing 
complex, with chromatin remodeling activities that repress transcription of the targeted 
retrotransposon and adjacent genes. Our biophysical and structural data show that the tripartite 
motif (TRIM) of KAP1 forms antiparallel dimers, which further assemble into tetramers and higher-
order oligomers in a concentration-dependent manner. Structure-based mutations in the B-box 1 20	
domain prevent higher-order oligomerization without significant loss of retrotransposon silencing 
activity, indicating that, in contrast to other TRIM-family proteins, self-assembly is not essential 
for KAP1 function. The crystal structure of the KAP1 TRIM dimer identifies the KRAB domain 
binding site, in the coiled-coil domain near the dyad. Mutations at this site abolished KRAB binding 
and transcriptional silencing activity of KAP1. This work identifies the interaction interfaces in the 25	
KAP1 TRIM responsible for self-association and KRAB binding and establishes their role in 
retrotransposon silencing. 
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Significance 
Retroviruses can integrate their DNA into the host-cell genome. Inherited retroviral DNA and other 
transposable elements account for over half of the human genome. Transposable elements must 
be tightly regulated to restrict their proliferation and prevent toxic gene expression. KAP1/TRIM28 35	
is an essential regulator of transposable element transcription. We determined the crystal 
structure of the KAP1 TRIM. The structure identifies a protein-protein interaction site required for 
recruitment of KAP1 to transposable elements. An epigenetic gene silencing assay confirms the 
importance of this site for KAP1-dependent silencing. We also show that KAP1 self-assembles in 
solution, but this self-assembly is not required for silencing. Our work provides insights into KAP1-40	
dependent silencing, and tools for expanding our mechanistic understanding of this process. 
/body 
Introduction 
Retrovirus genomes that integrate into the genome of germline cells are inherited by future 
generations. These endogenous retroviruses (ERVs) can retain the ability to replicate by 45	
transcriptional amplification and expression of the viral reverse transcriptase and integrase, which 
convert the genome transcripts into DNA and reintegrate it into the host genome. This amplifying 
retrotransposition mechanism has allowed ERVs, and other retroelements such as LINEs (long 
interspersed nuclear elements), to accumulate, accounting for over half of the human genome 
(1). Approximately 100 human LINEs are still replication-competent and cause new integration 50	
events in 2-5% of the population (2). 
Some ERVs and other transposable elements (TEs) have evolved to fulfill important cellular 
functions. TEs drive the evolution of transcriptional networks by spreading transcription factor 
binding sites, promoters and other regulatory elements (1, 3). TE-derived regulatory elements are 
particularly important in embryogenesis, when global hypomethylation promotes transcription. A 55	
significant fraction of pluripotency-associated transcription factor binding sites is located in TEs 
(1). TEs also serve as a reservoir of genes that can be coopted by the host. For example, TE-
derived proteins catalyze V(D)J recombination (4) and syncytiotrophoblast fusion in placental 
development (1, 5). 
Transcription of TEs must be tightly regulated, however, to prevent pathogenesis. Disruption of 60	
protein coding sequences by transposition events can cause genetic disorders such as 
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hemophilia and cystic fibrosis (6). TE reactivation in somatic cells is associated with cancer, 
through disruption of tumor suppressor genes or enhanced transcription of oncogenes (6, 7). 
Accumulation of TE-derived nucleic acids is associated with autoimmune diseases including 
geographic atrophy, lupus and Sjögren’s syndrome (2, 8). A key source of retroelement 65	
repression is the family of Krüppel-associated box zinc-finger proteins (KRAB-ZFPs) and KRAB-
associated protein 1 (KAP1, also known as TRIM28 or TIF1b) (9). KRAB-ZFPs, the largest family 
of mammalian transcription factors, recognize retroelements with a variable C-terminal array of 
zinc fingers (10, 11). The conserved N-terminal KRAB domain recruits KAP1 (9), which serves as 
a platform for the assembly of a transcriptional silencing complex of repressive chromatin-70	
modifying enzymes including SETDB1, a histone H3K9 methyltransferase, and the nucleosome 
remodeling and deacetylase (NuRD) complex (12). 
KAP1 is an 835-amino acid, 89-kDa protein from the tripartite motif (TRIM) family (Fig. 1A). 
Residues 57-413 contain the defining feature of the TRIM family: an RBCC motif consisting of a 
RING domain, two B-box-type zinc fingers and a coiled-coil domain. The RING has ubiquitin E3 75	
ligase activity (13). This activity can be directed to tumor suppressors AMPK and p53 by the 
MAGE proteins, which are overexpressed in human cancers (13, 14). The resulting proteasomal 
degradation of AMPK and p53 has been implicated in tumorigenesis (13, 14). The central region 
of KAP1 contains a PxVxL motif that recruits Heterochromatin Protein 1 (HP1) and is essential 
for transcriptional silencing (15). The C-terminal region of KAP1 contains a PHD-bromodomain 80	
tandem (residues 624-812). The PHD recruits the SUMO E2 ligase Ubc9, to SUMOylate several 
lysines in the bromodomain, thereby acting as an intramolecular SUMO E3 ligase (16, 17). KAP1 
SUMOylation is required for recruitment and activation of SETDB1 and recruitment of NuRD (15-
17). KAP1 has also been reported to SUMOylate IRF7 (18). The KAP1 RING was necessary (but 
not sufficient) and the PHD dispensable for IRF7 SUMOylation (18). Similarly, the RING of 85	
PML/TRIM19 is required but not sufficient for the SUMO E3 ligase activity of PML (19, 20). 
The KAP1 RBCC motif has been reported to form homotrimers and bind KRAB domains with a 
stoichiometry of 3:1 KAP1:KRAB (21, 22). However, this is inconsistent with more recent reports 
that TRIM5, TRIM25 and TRIM69 form antiparallel dimers, a property predicted to be conserved 
across the TRIM family (23-26). Moreover, various TRIMs (TRIM5, PML/TRIM19, TRIM32) further 90	
assemble into tetramers and higher-order oligomers, including two-dimensional lattices and 
molecular scaffolds (as seen in PML bodies), and these higher-order assemblies are important 
for their biological activities (25, 27-29). RING domains, including those of TRIM5a and TRIM32, 
form dimers, which contribute to E3 ligase activity by priming the associated E2 ubiquitin ligase 
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for ubiquitin transfer (28, 30, 31). The B-box 1 domain of TRIM19 (29) and B-box 2 domain of 95	
KAP1 (PDB: 2YVR) both also form dimers. Here, we use biophysical and structural approaches 
to show that KAP1 forms antiparallel dimers, which further assemble into tetramers and higher-
order oligomers in a concentration-dependent manner. Point mutants defective in higher-order 
oligomerization were not significantly impaired in their retroelement silencing activity in a cell-
based assay, indicating that self-assembly is not essential for the silencing function of KAP1. In 100	
contrast, mutation of conserved residues in the coiled-coil domain inhibited KRAB binding and 
transcriptional silencing. This work identifies the interaction interfaces in the KAP1 RBCC motif 
responsible for self-association and KRAB binding and establishes their role in retrotransposon 
silencing. 
Results 105	
KAP1 forms dimers that self-assemble into higher-order oligomers 
Each of the domains within the RBCC motif (RING, B-box 1, B-box 2 and coiled coil) has been 
reported to independently form dimers or oligomers in TRIM-family proteins (23-29). The 
presence of two or more domains capable of oligomerization independently can lead to 
polymerization of TRIMs into lattices or scaffolds (25, 27, 28), but it remains unclear whether this 110	
applies to KAP1. To assess the self-assembly potential of KAP1, we purified the KAP1 RBCC 
motif and some of its constituent domains to determine their hydrodynamic properties. Size-
exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) showed that the 
RING domain was monomeric at concentrations ranging from 0.1 to 1.1 mM (1-10.5 g L-1) (Fig. 
1B). A fragment containing the RING and B-box 1 domains was mostly monomeric at 33 µM (0.5 115	
g L-1) but as the protein concentration was increased to 610 µM (9.7 g L-1) the average 
hydrodynamic radius and apparent molecular weight of the protein increased by up to 33% (Fig. 
1C), indicating that monomers and dimers (or higher order oligomers) were in dynamic equilibrium 
with each other in solution. We conclude that B-box 1 drives assembly of RING-B-box 1 fragment 
into weakly associated dimers, with a dissociation constant in the low micromolar range. 120	
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Fig. 1. Self-assembly in solution of KAP1 RBCC and its subcomponent domains. (A) Domain 
organization of KAP1. B1, B-Box 1; B2, B-box 2. (B-D) SEC-MALS data for the RING, (B), 
RING-B-Box 1, (C), and RBCC, (D). (E) SE-AUC analysis of RBCC molecular weight as a 
function of protein concentration. The average molecular weight isotherm from individual fits at 125	
different concentrations was fitted to an isodesmic self-association model (black line) yielding 
dissociation constants of Kd2,4 = 9 µM [with a 1-s (68.3%) confidence interval of 7-11 µM] and 
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Kdiso = 19 µM [1-s confidence interval 16-23 µM] for the dimer-tetramer and isodesmic equilibria, 
respectively. An alternative fit to a dimer-tetramer-octamer model (grey line) yielded dissociation 
constants of Kd2,4 = 12.6 µM [1-s confidence interval 7.4-23.5 µM] and Kd4,8 = 6 µM [1-s 130	
confidence interval 3-11 µM] for the dimer-tetramer and tetramer-octamer equilibria, 
respectively. (F) SEC-MALS of full-length KAP1. 
SEC-MALS data for the whole RBCC showed unambiguously that it was dimeric at low protein 
concentrations (8.7 µM, 0.35 g L-1), and that its hydrodynamic radius and apparent molecular 
weight increased by up to 68% as the protein concentration was increased to 0.3 mM (12.4 g L-1) 135	
(Fig. 1D). The isolated KAP1 B-box 2 crystallized as a dimer with a surface area of 1,160 Å2 
buried at the dimer interface (PDB: 2YVR). Together, these data suggest that the coiled-coil 
domain of KAP1 forms tight homodimers, like most if not all other members of the TRIM family, 
and that KAP1 dimers can self-assemble through further weak homotypic interactions between 
the B-boxes to form higher-order oligomers. 140	
To obtain a more direct and quantitative model of KAP1 self-association we performed 
sedimentation equilibrium analytical ultracentrifugation (SE-AUC) on KAP1 RBCC at 
concentrations from 1 to 200 µM. The equilibrium sedimentation profiles were consistent with a 
dynamic equilibrium between dimeric and oligomeric KAP1 (SI Appendix, Fig. S1), in agreement 
with the SEC-MALS data. The average molecular mass at the lowest concentration was 145	
approximately 80 kDa (Fig. 1E), consistent with the formation of a dimer with a subnanomolar 
affinity. Further oligomerization was evident as the concentration increased. The observed 
increase in average molecular weight of KAP1 oligomers with increasing protein concentration at 
sedimentation equilibrium could be explained with two alternative models of self-association. The 
model with the best fit was an isodesmic self-association model in which KAP1 dimer to tetramer 150	
association is followed by unlimited consecutive additions of dimers (Fig. 1E). A simpler 4R2 → 
2R4 → R8 model with dimers, tetramers and octamers in dynamic equilibrium produced a fit of 
similar quality (Fig. 1E). In support of the isodesmic model, the weight-average fit residuals were 
slightly lower at the highest protein concentrations than for the dimer-tetramer-octamer model 
(Fig. 1E). However, the improved fit of the isodesmic model could stem from the greater number 155	
of parameters versus the dimer-tetramer-octamer model. Both models yielded a dimer-tetramer 
dissociation constant Kd2,4 and higher-order dissociation constants (Kd4,8 and Kdiso) of the order of 
10 µM. Full-length KAP1 self-assembled in a similar manner indicating that higher-order 
oligomerization is not an artifact of isolating the RBCC domain (Fig. 1F). We conclude that KAP1 
forms tight dimers, which can associate into tetramers and octamers at high local concentration 160	
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of KAP1. KAP1 may also form higher-order species but our SE-AUC data cannot definitively 
confirm or rule out the presence of KAP1 species larger than octamers. 
Crystal structure of the KAP1 RBCC tripartite motif (TRIM) 
To understand the molecular basis of KAP1 self-assembly and identify its oligomerization 
interfaces, we determined the crystal structure of KAP1 RBCC. Although crystals of KAP1 RBCC 165	
were readily obtained, they initially diffracted X-rays poorly. Crystals suitable for structure 
determination were obtained by fusing bacteriophage T4 lysozyme (T4L) to the N-terminus of 
KAP1 RBCC and methylating primary amines in the purified protein prior to crystallization (see 
Methods). Diffraction was anisotropic, with data up to 2.63 Å resolution but with overall 
completeness falling below 90% at 3.9 Å resolution (SI Appendix, Table S1). The structure was 170	
determined by single anomalous dispersion (SAD) phasing using the anomalous scattering signal 
from the zinc atoms in the RING and B-boxes. The asymmetric unit contained two molecules. The 
atomic model was refined at 2.9 Å resolution (SI Appendix, Fig. S2). 
The overall structure of the KAP1 RBCC dimer resembles a dumbbell (Fig. 2). The coiled-coil 
domain forms a 16 nm-long antiparallel coiled coil that contains all the dimer contacts. The ends 175	
of the coiled coil are capped by a B-box 2 domain. The RING domains (residues 63-138) are 
bound to one side of the coiled coil, close to but not in contact with the B-box 2 (residues 204-
243) from the same subunit. Unexpectedly, there was no interpretable electron density for B-box 
1 (residues 139-203), indicating that its position relative to the other domains is variable and does 
not obey the crystallographic symmetry. The T4L is rigidly linked to the RING domain via a 180	
continuous fused a-helix consisting of residues 158-162 from T4L (numbered 51-55 in the 
structure) and residues 56-62 from KAP1. The only other significant contacts between the N-
terminal fusion region and the KAP1 RBCC are through the tobacco etch virus (TEV) protease 
cleavage site, which precedes the T4L and, atypically, is mostly ordered in the structure (Fig. 2). 
The TEV cleavage sequence is sandwiched in an extended conformation between the T4L and 185	
the coiled coil, forming multiple polar and hydrophobic contacts with both domains. Although not 
physiologically relevant, these contacts appear to stabilize the crystal lattice by constraining the 
orientation of the T4L relative to KAP1 RBCC. The T4L also forms extensive crystal packing 
contacts, consistent with the improved diffraction properties of the T4L-RBCC crystals versus 
crystals of the RBCC alone. 190	
The coiled-coil domain forms a helical hairpin consisting of a 15 nm-long a-helix (residues 244-
348) followed by a turn and a shorter partially helical segment (residues 357-405). The first helical 
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segment contains the majority of the dimer contacts, mostly hydrophobic leucine zipper-type 
coiled-coil interactions with the first helical segment from the other subunit. The second segment 
packs against the first to form a four-helix bundle around the twofold axis of the dimer, where the 195	
second segments from the two subunits overlap (Fig. 2), and a three-helix bundle at the distal 
ends of the dimer, where the second segments do not overlap. The central portion of the second 
segment has poor electron density indicating a relatively high level of conformational flexibility. 
The coiled-coil domain is structurally most similar to the coiled-coil domain of TRIM25 (25, 26) 
(Rmsd 2.6 Å), which forms a dimeric antiparallel coiled coil with the same fold and similar length 200	
and curvature. TRIM5a forms a dimeric coiled coil with the same fold and length but lower 
curvature (23) (Rmsd 3.9 Å), and TRIM69 forms a dimeric coiled coil with different secondary 
structure (24) (Rmsd 4.0 Å). 
The KAP1 RING and B-box 2 do not form dimers in the RBCC crystal structure 
RING domains of E3 ubiquitin ligases recruit ubiquitin-conjugated E2 ligases to the substrate and 205	
prime ubiquitin transfer from the E2 ligase to the substrate by stabilizing the E2-ubiquitin 
intermediate in a closed state competent for transfer (31, 32). This stabilization has been 
proposed to be dependent on RING dimerization in TRIM5a, TRIM25, TRIM32 and BIRC-family 
E3 ligases (28, 30, 31). The most similar RING domain structure to the KAP1 RING domain is 
that of TRIM32 (28) (Rmsd 1.9 Å). However, in contrast to the TRIM32 RING, which dimerizes in 210	
solution via a-helices flanking the core RING domain (28), the KAP1 RING domains in the RBCC 
dimer are located on opposite ends of the coiled-coil domain and do not form any homotypic 
contacts. The KAP1 RING domains form crystal contacts with the coiled-coil domain (but not the 
RING domain) of a neighboring RBCC dimer. Similarly, the KAP1 B-box 2 domain also does not 
form homotypic contacts in the RBCC dimer. The B-box 2 domain does form crystal contacts with 215	
B-box 2 domains from two different neighboring RBCC dimers in the crystal lattice, but these 
homotypic contacts are distinct from those formed by the isolated B-box 2 in solution. The latter 
are moreover incompatible with the RBCC dimer structure as the coiled-coil domain blocks the B-
box 2 surface that mediates dimerization of the isolated B-box 2. 
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 220	
Fig. 2. Crystal structure of KAP1 RBCC. (A) Domain organization of the crystallized construct. 
T4L, T4 lysozyme; B1, B-Box 1; B2, B-box 2; CC, coiled-coil. (B) Overall structure of the RBCC 
homodimer. Three views along or perpendicular to the dyad are shown. The components are 
colored as in (A). Zn atoms are shown as magenta spheres. (C) View of the RBCC dimer 
perpendicular to the dyad, with one subunit shown as a cartoon and the other as a surface. 225	
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Higher-order assembly of KAP1 dimers is dependent on B-box 1 interactions 
Our hydrodynamic data indicate that KAP1 dimers self-assemble into tetramers, octamers and 
higher-order oligomers through one or both of the B-boxes. To identify the sites responsible for 
higher-order oligomerization of KAP1, we designed structure-based mutations in the B-boxes 230	
aimed at disrupting potential dimer contacts (Fig. 3). In B-box 2, a cluster of residues involved in 
homotypic crystal contacts was mutated, yielding the variant 
N235A/A236D/K238A/D239A/F244A/L245A (Fig. 3A). Residues in the RING domain forming 
crystal contacts (with the coiled-coil domain) were mutated in a second variant, 
V114A/Q123A/F125A/K127A (Fig. 3A). Since B-box 1 was disordered in the RBCC structure, we 235	
mutated residues predicted to be involved in B-box 1 dimerization based on a structural model of 
the KAP1 B-box 1 dimer generated from the TRIM19 B-box 1 dimer structure (PDB: 2MVW) (29), 
yielding the variant A160D/T163A/E175R (Fig. 3B). The oligomerization potential of each of these 
variants was then assessed by SEC-MALS. Mutations in the RING and B-box 2 domains did not 
alter the self-assembly properties of KAP1 RBCC (Fig. 3C and D). The latter was unexpected 240	
since a crystal structure of the isolated KAP1 B-box 2 was dimeric (PDB: 2YVR). In contrast, the 
B-box 1 mutations abolished oligomerization of the RING-Box-1 fragment and almost completely 
inhibited higher-order oligomerization of KAP1 RBCC dimers (Fig. 3E and F). We conclude that 
the assembly of KAP1 RBCC dimers observed at high protein concentration occurs primarily 
through dimerization of B-box 1 domain (Fig. 3G). 245	
 11 
 
Fig. 3. Self-assembly properties and KRAB binding activity of KAP1 RBCC mutants. (A) 
Positions of the mutations in the RING and B-box 2 domains. A reference RBCC dimer is 
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colored as in Fig. 2. Adjacent RBCC dimers forming crystal packing contacts are shown in grey 
with their residue numbers followed by an asterisk. (B) Model of a KAP1/TRIM28 B-box 1 dimer 250	
based on the TRIM19 B-box 1 dimer structure (29) with selected residues forming dimer 
contacts shown. An alignment of B-box 1 sequences (right), the TRIM28 B-box 1 model, and the 
TRIM19 B-box 1 structure were used to identify mutations in KAP1 B-box 1 likely to disrupt 
dimer contacts. Residues known or predicted to participate in dimer contacts are shown in bold 
typeface in the sequence alignment. (C-F) SEC-MALS data for: (C) RBCC with RING domain 255	
mutations, (D) RBCC with the B-box 2 mutations, (E) RING-B-box 1 with B-Box 1 mutations, (F) 
RBCC (black curve, WT; red curve, B-Box 1 mutant A160D/T163A/E175R). (G) Model for 
oligomerization of KAP1 via B-Box 1. 
Self-assembly of KAP1 RBCC dimers is not required for retroelement silencing 
Various TRIM proteins assemble into higher-order oligomers, two-dimensional lattices or 260	
molecular scaffolds that are important for physiological function (25, 27-29). To determine whether 
self-assembly of KAP1 into higher-order oligomers is required for its retroelement repression, we 
assayed the transcriptional silencing activities of wild type KAP1 and the oligomerization-deficient 
mutant. We used reporter constructs in which sequences from an SVA-D (SINE–Variable number 
tandem repeat–Alu, type D) retroelement (recognized by ZNF91) or a LINE-1 retroelement 265	
(recognized by ZNF93) cloned upstream of a minimal SV40 promoter strongly enhance firefly 
luciferase activity unless the respective KRAB-ZFP and KAP1 are both present to repress the 
reporter (11). The assay was adapted for use in KAP1-knockout (KO) HEK 293T cells (33), which 
were cotransfected with the reporter plasmid and plasmids encoding ZNF91 or ZNF93, KAP1 (WT 
or mutant) and Renilla luciferase under a constitutive promoter. Firefly luciferase luminescence 270	
from the reporter was normalized against the cotransfected Renilla luciferase to control for 
transfection efficiency. Mutations in the HP1-binding motif of KAP1 (R487E/V488E) abolished its 
transcriptional activity, while disruption of the PHD (C651A) resulted in moderate derepression of 
the reporter, consistent with previous reports (16, 34). Unexpectedly, however, the 
A160D/T163A/E175R B-box 1 variant had a similar repression activity as WT on the SVA and 275	
LINE-1 reporters, despite being deficient in dimer-dimer assembly (Fig. 4). We therefore conclude 
that self-assembly of KAP1 RBCC dimers into higher-order oligomers is not required for KAP1-
dependent transcriptional silencing of the SVA/LINE-1 retroelements under the assay conditions. 
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Fig. 4. Transcriptional silencing assays with KAP1 mutants. Data are presented as fold-280	
repression of reporter luciferase luminescence in KAP1 KO HEK293T cells transfected with a 
KAP1 variant. (A) SVA reporter repression with the oligomerization-deficient B-box 1 mutant 
(B1mut), the KRAB binding-deficient coiled-coil mutant (CCmut), an HP1-box mutant (HP1mut) 
and a PHD mutant (PHDmut). (B) LINE-1 reporter repression with the same set of mutants as in 
(A). Data were normalized to KAP1 KO cells transfected with an empty vector (EV).	Error bars 285	
represent standard error of the mean between measurements; n = 3. Lower panels: Western 
blots of cell lysates from WT or KAP1 KO HEK293T cells transfected with each of the variants 
(WT, CC, B1, HP1, PHD) or empty vector (-). 
Conserved residues in the CC domain bind a KRAB domain and are required for silencing 
The primary function of the RBCC domain of KAP1 in silencing is to bind the KRAB domains of 290	
KRAB-ZFPs and hence recruit KAP1 to its genomic targets. KRAB:KAP1 complexes were 
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previously reported as containing one KRAB molecule and three KAP1 molecules (21, 22). 
However, this seemed unlikely given that KAP1 is dimeric so we decided to reexamine the 
composition of KRAB:KAP1 complexes. A complex of KAP1 and the KRAB domain from ZNF93, 
a KRAB-ZFP that binds to a LINE-1 element known to be silenced by KAP1 (11), was 295	
reconstituted by coexpressing the proteins in E.coli. SEC-MALS analysis showed that KAP1 and 
ZNF93 KRAB formed a stable complex, which retained the same ability to self-assemble into 
higher-order oligomers as KAP1 alone (SI Appendix, Fig. S3A). The average molecular mass 
derived from SEC-MALS for the KAP1-KRAB complex of 226 kDa was inconsistent with a 1:3 
KRAB:KAP1 stoichiometry and suggested instead the stoichiometry of the complex was 1:2 300	
KRAB:KAP1 (236 kDa theoretical molecular weight; Fig. 5A). 
Having established that each RBCC dimer binds a single KRAB domain, we reasoned that the 
interaction interface must be located on the dyad, in the central region of the KAP1 coiled-coil 
domain, as every other location would result in two equivalent binding sites (and a 2:2 
stoichiometry). Intriguingly, examination of our KAP1 RBCC crystal structure revealed a cluster 305	
of solvent-exposed hydrophobic residues near the twofold axis (V293, M297, L300; Fig. 5B). 
Moreover, these amino acids are conserved in KAP1 but not present in other TRIMs (SI 
Appendix, Fig. S4). To determine whether this region of the coiled-coil domain mediates KRAB 
binding, we designed the variant V293S/K296A/M297A/L300S (Fig. 5B). KAP1 RBCC domain 
bearing these mutations failed to bind to MBP-KRAB in a pulldown assay (Fig. 5C). Other 310	
properties of KAP1 such as dimerization and higher-order oligomerization were unaffected (SI 
Appendix, Fig. S3B), indicating that the mutations did not interfere with the overall fold of the 
RBCC domain. Notably, the thermal stability of this variant as assessed by differential scanning 
fluorimetry (DSF) was significantly higher than that of WT RBCC domain, further supporting a 
functional role of these residues (SI Appendix, Fig. S3C). A second variant with mutations on 315	
the dyad on opposite face of the coiled-coil domain, F391A/L395S/W398A, was mostly insoluble. 
The lack of binding of the V293S/K296A/M297A/L300S variant to MBP-KRAB was confirmed with 
surface plasmon resonance (SPR) measurements. While WT RBCC domain bound MBP-tagged 
KRAB domain with high affinity (8 ± 2 nM Kd), no binding was observed with the coiled-coil mutant 
(Fig. 5D and SI Appendix, Fig. S5). 320	
The effect of the coiled-coil mutations on the transcriptional silencing activity of KAP1 was 
measured using the reporter assay described above. Consistent with its inability to bind KRAB 
the V293S/K296A/M297A/L300S variant lost all repression activity, while being expressed at 
similar concentrations as WT KAP1 (Fig. 4). These data indicate that KRABs bind KAP1 on the 
 15 
twofold axis of the RBCC dimer on a surface that includes residues V293/K296/M297/L300 and 325	
that this binding surface is required for KAP1 repression activity. 
 
Fig. 5. Formation of a 2:1 KAP1:KRAB complex and identification of KRAB binding residues in 
the KAP1 coiled-coil domain required for silencing. (A) SEC-MALS of full-length KAP1 bound to 
ZNF93 MBP-KRAB. The expected molecular weights of a KAP1 dimer, and for 2:1 and 2:2 330	
KAP1:KRAB complexes are indicated with dashed lines. The total protein concentration of each 
analyte was 1.2 g l-1. (B) Closeup of the cluster of solvent-exposed hydrophobic residues near 
the dyad. The variant V293S/K296A/M297A/L300S (CC mutant) was generated to test for 
KRAB binding. (C) Pulldown KAP1-KRAB binding assay. KAP1 RBCC was incubated with Twin-
StrepII-MBP-ZNF93 KRAB and the mixture loaded on Strep-Tactin Sepharose. Bound proteins 335	
were detected by SDS-PAGE/Coomassie. (D) SPR KAP1-KRAB binding assay. MBP-KRAB 
was immobilized on the chip. WT or CC mutant KAP1 RBCC were flowed over the chip. Binding 
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kinetics of WT RBCC: kon = 3.6 ± 0.96  x 104 M-1 s-1; koff = 2.7 ± 0.1 x 10-4  s-1. (E) Model for 
binding of KAP1 dimers to KRAB-ZFPs. 
Discussion 340	
Initial biophysical studies on the KAP1 RBCC domain suggested that it formed trimers, both in 
isolation and in complex with a KRAB domain (21, 22). More recent work on other TRIMs, in 
contrast, demonstrated that the coiled-coil domains of various TRIMs mediate formation of 
antiparallel dimers and suggests that this property is conserved across the entire TRIM family 
(23-26). Our SEC-MALS and SE-AUC data establish that KAP1 is dimeric rather than trimeric, 345	
and that dimers self-assemble into tetramers, octamers and possibly higher-order species at high 
local concentration of KAP1. Notably, the cooperativity of self-assembly implies that octamers are 
slightly more stable than tetramers, which could in principle promote the formation of large 
oligomeric assemblies of KAP1 in the nucleus. This concentration-dependent self-association of 
KAP1 is primarily encoded by B-box 1 and is relatively weak with a dissociation constant in the 350	
low micromolar range. The lack of a discrete endpoint oligomeric state (e.g. tetramers) led us to 
hypothesize that the RBCC may be able to self-associate into polymeric chains or molecular 
scaffold (Fig. 3G) as observed for other TRIMs (25, 27-29). We therefore investigated the 
possibility that KAP1 self-assembly may contribute to its transcriptional silencing function. 
Conceivably, formation of large oligomeric assemblies of KAP1 at its genomic target loci might 355	
amplify silencing activity by increasing the number of recruited repressive chromatin-modifying 
molecules such as SETDB1. However, KAP1 mutants deficient in self-assembly repressed 
transcription from SVA and LINE-1 reporter retrotransposons with an efficiency similar to WT 
KAP1, indicating that at least in this setting higher-order oligomerization is not absolutely required 
for KAP1 function. 360	
The KAP1 RING has ubiquitin E3 ligase activity (13). E3 ligase activity is generally thought to be 
dependent on RING dimerization, in the context of RBCC dimerization, in TRIM5a, TRIM25, 
TRIM32 and BIRC-family E3 ligases (28, 30, 31). Unexpectedly, the crystal structure of KAP1 
RBCC is incompatible with RING dimerization as the RING domains are positioned on opposite 
ends of the RBCC dimer (Fig. 2B). Furthermore, the KAP1 RINGs do not form significant crystal 365	
contacts and do not dimerize or self-associate in solution. The absence of homotypic contacts 
between the RINGs  (or B-box 2 domains) in the RBCC dimer suggests that KAP1 may be 
amongst the minority of E3 ligases that can promote ubiquitin transfer from E2 to substrate without 
forming RING dimers, perhaps using structural elements from outside the core RING domain as 
seen for example in CBL-B (32). Alternatively, the primary function of the RING may be to 370	
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contribute to SUMO E3 ligase activity, consistent with reports that the RINGs of KAP1 (18) and 
PML (19, 20) are required for SUMOylation of specific substrates. 
The interaction between KAP1 and KRAB-ZFPs is critical for recruitment of KAP1 to 
retroelements, but the stoichiometry of KAP1-KRAB complexes has remained unclear and the 
location of the KRAB binding surface on KAP1 unknown. Our SEC-MALS data shows 375	
unambiguously that the KAP1 RBCC dimer can only bind a single KRAB domain. Moreover, we 
demonstrate that KRAB binding occurs on the dyad of the RBCC dimer on a surface that includes 
residues V293/K296/M297/L300, and that this interface is required for KAP1 repression activity. 
It was previously proposed that RING domain, B-box 2 and coiled-coil domain of KAP1 all 
contribute to KRAB binding (21, 22). However, these results were inferred from mutations in 380	
residues essential for maintaining the structural integrity of the KAP1 RBCC dimer that would 
likely cause misfolding of the protein. Based on the distance of the B-box 2 from the KRAB-binding 
residues in the coiled-coil domain and the small size of KRAB domains, direct involvement of B-
box 2 in KRAB binding can be ruled out (Fig. 5E). Similarly, a contribution of the RING, which is 
also distant from the dyad, appears highly unlikely. We note that since a single KRAB domain 385	
binds to the RBCC dimer on (or near) the dyad, the contacts formed by the KRAB domain with 
each of the KAP1 protomers in the dimer are necessarily different, lending an inherent asymmetry 
to the KRAB:KAP1 interaction. Hence, loss of twofold symmetry in the KRAB:KAP1 complex is a 
consequence of KRAB binding to the dyad. 
We have mapped the specific molecular features within the KAP1 RBCC domain that are 390	
responsible for KAP1 self-assembly and KRAB binding. We show that binding of a single KRAB 
domain to the dimeric antiparallel coiled-coil domain of KAP1 is the first step in KAP1-
depedendent epigenetic silencing of retrotransposon transcription. Further studies, informed by 
the work reported here, are needed to complete our understanding of how KAP1 recognizes 
KRAB-ZFPs, how it activates chromatin-modifying enzymes in subsequent steps of transcriptional 395	




Synthetic genes encoding KAP1 RING (residues 50-146), RING-B-box 1 (RB1; residues 50-200), 400	
RBCC (residues 50-413) and full-length KAP1 (residues 1-835; UniProt: Q13263) codon-
optimized for Escherichia coli (E. coli) were cloned into the first multiple cloning site (MCS) of the 
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pETDuet plasmid (Novagen), with N-terminal hexahistidine purification (His6) tag followed by a 
TEV protease cleavage site (ENLYFQG). The T4L-RBCC fusion construct was constructed by 
inserting a synthetic gene encoding the RBCC motif (residues 56-413) of human KAP1 codon-405	
optimized for E.coli into the first MCS of pETDuet. The gene was preceded by sequences 
encoding: a His6 tag; a TEV protease cleavage site; and bacteriophage T4 lysozyme (T4L) with 
the N-terminal methionine deleted and the last three residues replaced by a single alanine 
residue. A synthetic gene encoding the KRAB domain (residues 1-71) from ZNF93 (UniProt: 
P35789) codon-optimized for E.coli was expressed from the pET20 plasmid (Novagen) with N-410	
terminal Twin-StrepII and maltose binding protein (MBP) affinity tags (the MBP tag was also 
required for protein solubility). For coexpression with KAP1, the same ZNF93 KRAB construct 
was subcloned into MCS1 of pCDFDuet. 
KAP1 RBCC and the KRAB domain of ZNF93 were coexpressed from the pETDuet plasmid. A 
synthetic gene encoding residues 50-413 of KAP1 codon-optimized for E.coli was inserted into 415	
MCS1 adding an N-terminal His6 tag followed by a TEV protease cleavage site. A synthetic gene 
encoding residues 1-71 of ZNF93 codon-optimized for E.coli was cloned into MCS2 adding an N-
terminal glutathione S-transferase (GST) followed by a human rhinovirus (HRV) 3C protease 
cleavage site. 
For the transcriptional silencing assay, expression constructs containing WT or mutant full-length 420	
human KAP1 preceded by a triple FLAG tag and linker sequence 
MDYKDHDGDYKDHDIDYKDDDDKGSGG were assembled in pLEXm (35) with the NEBuilder 
HiFi DNA Assembly Cloning Kit (New England BioLabs). The following plasmids were used: firefly 
luciferase reporter plasmids pGL4cp-VNTR-OCT4Enh-E2 and pGL4cp-L1PA4-OCT4Enh-E2; 
pCAG_ZNF91_HA encoding ZNF91; pCAG_ZNF93 encoding ZNF93; and pRTTK_Renilla 425	
encoding Renilla luciferase under a constitutive promoter (33). 
Protein expression and purification 
E. coli BL21 (DE3) cells (New England BioLabs) were transformed with the respective expression 
construct and starter cultures were grown overnight at 30˚C in 2×TY medium. Starter cultures 
were used to inoculate 2×TY medium and cells were incubated at 37˚C and 220 rpm to an optical 430	
density (OD600) of 0.4-0.5. For the expression of KAP1 constructs, cultures were then 
supplemented with 50 µM ZnSO4 and the temperature of the incubator was set to 18˚C. In the 
case of KRAB domain constructs, the incubator temperature was lowered to 16˚C. Protein 
expression was induced at OD600 = 0.8 with 0.2 mM isopropyl-β-D- thiogalactopyranoside (IPTG). 
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All subsequent steps were performed at 4˚C. After 16 h cells were harvested by centrifugation, 435	
and stored at -80˚C. 
To purify the RBCC domain of KAP1 cells were resuspended in lysis buffer containing 50 mM Tris 
pH 8, 0.3 M NaCl, 20 mM imidazole, 0.5 mM TCEP, 1:10,000 (v/v) benzonase solution (Sigma), 
1×cOmplete EDTA-free protease inhibitors (Roche). The cells were lysed by sonication 
immediately after addition of 1 mM phenylmethane sulfonyl fluoride (PMSF). The lysate was 440	
clarified by centrifugation (30 min, 40,000×g). The supernatant was applied to a 5-ml HisTrap HP 
nickel-affinity column (GE Healthcare) preequilibrated in wash buffer (50 mM Tris pH 8, 0.3 M 
NaCl, 20 mM imidazole, 0.5 mM TCEP). The column was washed with 30 column volumes (CV) 
of wash buffer before elution with elution buffer (50 mM Tris pH 8, 0.3 M NaCl, 0.25 M imidazole, 
0.5 mM TCEP). Subsequently, the buffer was exchanged to 50 mM Tris pH 8, 0.3 M NaCl, 0.5 445	
mM TCEP and the His6 tag was removed by incubating the protein overnight at 4˚C with 1:50 
(w/w) TEV protease. Following a second nickel-affinity chromatography step to remove uncleaved 
protein and protease, the sample was further purified by size-exclusion chromatography using a 
HiLoad (16/600) Superdex 200 pg column (GE Healthcare) preequilibrated in 20 mM HEPES pH 
8, 0.5 M NaCl, 0.5 mM TCEP. 450	
RING and RB1 constructs were purified as described above, except that a Superdex 75 (10/300) 
column (GE Healthcare) equilibrated in 20 mM HEPES pH 8, 0.2 M NaCl, 0.5 mM TCEP was 
used for the final size-exclusion chromatography step. T4L-RBCC fusion protein was purified as 
the RBCC domain, except that the His6 tag was not removed. Full-length KAP1 was purified as 
T4L-RBCC, except that a Superose 6 increase (10/300) column (GE Healthcare) preequilibrated 455	
in 20 mM HEPES pH 8, 0.2 M NaCl, 0.5 mM TCEP was used for the final size-exclusion 
chromatography step. 
To purify MBP-tagged ZNF93 KRAB domain, bacteria pellets were resuspended in lysis buffer 
(50 mM Tris pH 8, 0.15 M NaCl, 0.5 mM TCEP, 1:10,000 (v/v) benzonase solution (Sigma), 
1×cOmplete EDTA-free protease inhibitors (Roche)) and lysed by sonication. The lysate was 460	
clarified by centrifugation (30 min, 40,000×g). The supernatant was applied to a 5 ml StrepTrap 
column (GE Healthcare) preequilibrated in wash buffer (50 mM Tris pH 8, 0.15 M NaCl, 0.5 mM 
TCEP). The column was washed with 30 CV of wash buffer, before the protein was eluted with 
wash buffer supplemented with 2.5 mM D-desthiobiotin and further purified by size-exclusion 
chromatography using a HiLoad (16/600) Superdex 200 pg column (GE Healthcare) 465	
preequilibrated in 20 mM HEPES pH 8, 0.5 M NaCl, 0.5 mM TCEP. 
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KAP1:MBP-KRAB complex was purified as the isolated KRAB domain, except that lysis and wash 
buffer contained 0.2 M NaCl and a Superose 6 increase (10/300) column was used for the final 
size-exclusion chromatography step. 
Size-exclusion chromatography and multiangle light scattering (SEC-MALS) 470	
100 µl of protein sample was subjected to SEC at 293 K on a Superdex 200 (10/300) column (GE 
Healthcare) preequilibrated in 20 mM HEPES pH 8, 0.5 M NaCl, 0.5 mM TCEP (for KAP1 RBCC), 
a Superose 6 (10/300) column in 20 mM HEPES pH 8, 0.2 M NaCl, 0.5 mM TCEP (for full-length 
KAP1), a Superose 6 (10/300) column in 20 mM HEPES pH 8, 0.5 M NaCl, 0.5 mM TCEP (for 
KAP1:MBP-KRAB complex) or a Superdex 75 (10/300) column in 20 mM HEPES pH 8, 0.2 M 475	
NaCl, 0.5 mM TCEP (for RING and RB1 constructs) with a flow rate of 0.5 ml min-1. The SEC 
system was coupled to multi-angle light scattering (MALS) and quasi-elastic light scattering 
(QELS) modules (DAWN-8+, Wyatt Technology). Protein in the eluate was also detected with a 
differential refractometer (Optilab T-rEX, Wyatt Technology) and a UV detector at 280 nm (1260 
UV, Agilent Technology). Molar masses of peaks in the elution profile were calculated from the 480	
light scattering and protein concentration, quantified using the differential refractive index of the 
peak assuming a dn/dc of 0.186, using ASTRA6 (Wyatt Technology). 
Sedimentation-equilibrium analytical ultracentrifugation (SE-AUC) 
KAP1 RBCC samples at 0.2 mM (8 g l-1) and 12 µM (0.5 g l-1) were diluted in a 1:3 series in 20 
mM HEPES pH 8, 0.5 M NaCl, 0.5 mM TCEP. 110 µL samples were loaded in 12 mm 6-sector 485	
cells and centrifuged at 5, 8.5 and 15 krpm at 20˚C in an An50Ti rotor in an Optima XL-I analytical 
ultracentrifuge (Beckmann). At each speed, comparison of several scans was used to judge 
whether equilibrium had been reached. The data were analyzed in SEDPHAT 13b (36). 
Equilibrium sedimentation distributions were fit to obtain average masses. An SE-AUC average 
mass isotherm compiled from fits to the data was analyzed in SEDPHAT using isodesmic and 490	
dimer-tetramer-octamer oligomerization models. The partial-specific volumes (v-bar), solvent 
density and viscosity were calculated with Sednterp (www.rasmb.org/sednterp). 
X-ray crystallography 
Prior to crystallization, free amines in T4L-RBCC were methylated by incubating 15 ml of protein 
solution (~1 g L-1) in 20 mM HEPES pH 8, 0.5 M NaCl with 300 µl of 1 M dimethylamine borane 495	
complex (ABC; Sigma-Aldrich) and 600 µl of 1 M formaldehyde for 2 h at 4˚C. An additional 300 
µl of 1 M ABC and 600 µl of formaldehyde were then added. After further 2 h at 4˚C, 150 µl of 
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ABC was added and the sample was incubated overnight at 4˚C. The reaction was then quenched 
with 1.875 ml of 1 M Tris pH 8. The sample was supplemented with 2 mM DTT and purified with 
a HiLoad (16/600) Superdex 200 pg column preequilibrated in 20 mM HEPES pH 8, 0.5 M NaCl, 500	
0.5 mM TCEP (37). Crystals were grown at 18˚C by sitting drop vapor diffusion. Methylated T4L-
RBCC at 4.5 g L-1 (72 µM) was mixed with an equal volume of reservoir solution optimized from 
the Index screen (Hampton Research): 15% (w/v) PEG 3350, 75 mM MgCl2, 0.1 M HEPES pH 
7.5. Plate-shaped crystals appeared after 2 days and were frozen in liquid nitrogen with 33% 
ethylene glycol as a cryoprotectant. X-ray diffraction data were collected at 100 K at Diamond 505	
Light Source (beamline I03) and processed with autoPROC (38) and STARANISO (Global 
Phasing, Ltd). The X-ray energy was tuned to 9,672 eV, corresponding to the zinc L-III edge, for 
data collection. Phases were determined with the single anomalous dispersion (SAD) method in 
PHENIX (39) using zinc as the anomalously scattering heavy atom. Comparison of electron 
density maps calculated with different high-resolution cutoffs and B-factor sharpening factors (SI 510	
Appendix, Fig. S2) indicated that a 2.9-Å cutoff and -33 Å2 sharpening factor produced the best 
map. The atomic model was built with COOT (40) and iteratively refined with REFMAC (41) and 
PHENIX at 2.9 Å resolution. The atomic models for T4 lysozyme (PDB: 1LYD, 2LZM) and KAP1 
B-box 2 (PDB: 2YVR) were docked into the phased electron density and the rest of the atomic 
model was built de novo using available structures of other TRIMs as guides (PDB: 4LTB (25), 515	
4TN3 (23), 5FEY (28), 5NT1 (26)). See SI Appendix for data collection and refinement statistics 
(Table S1), and sample electron density (Fig. S2). Structure figures were generated with PyMOL 
(Schrodinger, LLC). Methylation of T4L-RBCC at 38 sites was confirmed by mass spectrometry 
(SI Appendix, Fig. S6), but none of the dimethyl-amine groups were visible in the map. 
Atomic model of KAP1 B-box 1 520	
An atomic model of the KAP1 B-box 1 domain was generated from the TRIM19 B-box 1 structure 
(PDB: 2MVW) (29) with Phyre2 (www.sbg.bio.ic.ac.uk/phyre2). The KAP1 B-box 1 was then 
superimposed onto each protomer of the TRIM19 B-box 1 dimer to generate a model of the KAP1 
B-box 1 dimer. 
Pulldown assay 525	
8 nmol of KAP1 RBCC was incubated with 2 nmol of Twin-StrepII-MBP-KRAB for 45 min on ice. 
StrepII-tagged bait protein was then captured with 100 µl of Strep-Tactin Sepharose (IBA) for 1 h 
at 4˚C. After four washes with 1 ml of buffer (20 mM HEPES pH 8, 0.5 M NaCl, 0.5 mM TCEP), 
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the beads were boiled in 100 µl of 2×SDS-PAGE loading buffer and bound proteins analyzed by 
SDS-PAGE/Coomassie. 530	
Surface plasmon resonance (SPR) 
SPR was performed using a Biacore T200 with dextran-coated CM5 chips (GE Healthcare). 
Reference control and analyte CM5 chips were equilibrated in 20 mM HEPES pH 8.0, 0.5 M NaCl, 
0.5 mM TCEP at 20˚C. MBP-KRAB was immobilized onto the chips until a response unit value of 
approximately 600 was reached. SPR runs were performed with analytes injected for 120 s 535	
followed by a 900 s dissociation in 1:2 dilution series with initial concentrations of 34 µM for WT 
KAP1 and 35 µM for mutant KAP1. The sensor surface was regenerated after each injection cycle 
with 20 mM NaOH for 30 s with a 120-s post-regeneration stabilization period. Data were fitted 
using a biphasic kinetic model with KaleidaGraph (Synergy Software) and PRISM 8 (GraphPad) 
to determine kon, koff and Kd. 540	
Transcriptional silencing assay 
KAP1 silencing activity was measured with a reporter assays in which a SINE-VNTR-Alu (SVA)  
type D or LINE-1 sequence upstream of a minimal SV40 promoter enhances firefly luciferase 
activity unless KAP1 and the cognate KRAB-ZFP (ZNF91 and ZNF93, respectively) are present 
to repress the reporter (11). The assay was adapted for use in HEK293T cells as described (33). 545	
KAP1 KO 293T cells in 24-well plates were cotransfected with 20 ng firefly luciferase reporter 
plasmid, 0.2 µg plasmid encoding ZNF91 or ZNF93, 0.2 µg pLEXm plasmid encoding WT or 
mutant KAP1 and 0.4 ng plasmid encoding Renilla luciferase using 1.5 µl of FuGENE 6 
(Promega). Luciferase activity was measured 48 h post-transfection in cell lysates with the Dual 
Luciferase assay kit (Promega) and a Pherastar FS platereader (BMG Labtech). Replicates were 550	
performed on separate days. Firefly luciferase values were normalized to Renilla luciferase values 
to control for transfection efficiency. 
Western blotting 
4 x 105 HEK293T cells were lysed in 100 µl Passive Lysis Buffer (Promega). 10 µl of cell lysates 
were boiled with 2.5 µl 4x gel loading buffer for 5 min at 98˚C and run on a NuPAGE 4-12% Bis-555	
Tris polyacrylamide gel for 45 min at 200 V. Gels were blotted using an iBlot Gel Transfer Device 
and Transfer Stacks (ThermoFisher). Blots were blocked with 5% milk in PBS for 1 h at room 
temperature and incubated with primary antibody overnight at 4˚C. Rabbit anti-KAP1 antibody 
(Abcam ab10484) was diluted 1:10,000 whilst rabbit anti-actin antibody (Abcam ab219733) was 
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diluted 1:2,000. Blots were incubated with fluorescent secondary antibodies for 30 min at room 560	
temperature. Secondary anti-rabbit antibodies were diluted 1:10,000. Blots were imaged using an 
Odyessy CLx gel scanner (LI-COR Biosciences). 
Statistics 
For the KAP1 complementation assays, data are representative of five independent experiments 
and statistical significance was assessed using an unpaired t-test (assuming Gaussian 565	
distributions, without Welch’s correction) with PRISM 8. Repression activity data are represented 
as the mean ± s.e.m.	Statistical significance was assigned as follows: n.s., P > 0.05; *, P < 0.05; 
**, P < 0.01, n = 3. 
Data availability 
The structure factors and atomic coordinates were deposited in the Protein Data Bank (PDB: 570	
6QAJ). The original experimental X-ray diffraction images were deposited in the SBGrid Data 
Bank (Dataset 637). Other data are available from the corresponding author upon request. 
Acknowledgments 
KAP1 KO cells and plasmids for the transcriptional silencing assay were kind gifts from Helen 
Rowe (University College London). The plasmids were provided with permission from David 575	
Haussler (Univ. of California Santa Cruz). We thank Christopher Douse and other members of 
the Modis lab for insightful discussions. Crystallographic data were collected on beamline I03 at 
Diamond Light Source (DLS). Access to DLS (proposal MX15916) was supported by the 
Wellcome Trust, MRC and BBSRC. This work was supported by Wellcome Trust through Senior 
Research Fellowship 101908/Z/13/Z to YM and PhD Studentship 205833/Z/16/Z to GS. 580	
References 
1. Friedli M, Trono D (2015) The developmental control of transposable elements and the 
evolution of higher species. Annu Rev Cell Dev Biol 31:429-451. 
2. Goodier JL (2016) Restricting retrotransposons: a review. Mob DNA 7:16. 
3. Chuong EB, Elde NC, Feschotte C (2016) Regulatory evolution of innate immunity through 585	
co-option of endogenous retroviruses. Science 351:1083-1087. 
4. Zhou L, et al. (2004) Transposition of hAT elements links transposable elements and V(D)J 
recombination. Nature 432:995-1001. 
5. Dupressoir A, Lavialle C, Heidmann T (2012) From ancestral infectious retroviruses to bona 
fide cellular genes: role of the captured syncytins in placentation. Placenta 33:663-671. 590	
 24 
6. Hancks DC, Kazazian HH, Jr. (2016) Roles for retrotransposon insertions in human 
disease. Mob DNA 7:9. 
7. Lamprecht B, et al. (2010) Derepression of an endogenous long terminal repeat activates 
the CSF1R proto-oncogene in human lymphoma. Nat Med 16:571-579, 571p following 579. 
8. Hung T, et al. (2015) The Ro60 autoantigen binds endogenous retroelements and regulates 595	
inflammatory gene expression. Science 350:455-459. 
9. Ecco G, Imbeault M, Trono D (2017) KRAB zinc finger proteins. Development 144:2719-
2729. 
10. Imbeault M, Helleboid PY, Trono D (2017) KRAB zinc-finger proteins contribute to the 
evolution of gene regulatory networks. Nature 543:550-554. 600	
11. Jacobs FM, et al. (2014) An evolutionary arms race between KRAB zinc-finger genes 
ZNF91/93 and SVA/L1 retrotransposons. Nature 516:242-245. 
12. Cheng CT, Kuo CY, Ann DK (2014) KAPtain in charge of multiple missions: Emerging roles 
of KAP1. World J Biol Chem 5:308-320. 
13. Doyle JM, Gao J, Wang J, Yang M, Potts PR (2010) MAGE-RING protein complexes 605	
comprise a family of E3 ubiquitin ligases. Mol Cell 39:963-974. 
14. Pineda CT, et al. (2015) Degradation of AMPK by a cancer-specific ubiquitin ligase. Cell 
160:715-728. 
15. Iyengar S, Farnham PJ (2011) KAP1 protein: an enigmatic master regulator of the genome. 
J Biol Chem 286:26267-26276. 610	
16. Ivanov AV, et al. (2007) PHD domain-mediated E3 ligase activity directs intramolecular 
sumoylation of an adjacent bromodomain required for gene silencing. Mol Cell 28:823-837. 
17. Zeng L, et al. (2008) Structural insights into human KAP1 PHD finger-bromodomain and its 
role in gene silencing. Nat Struct Mol Biol 15:626-633. 
18. Liang Q, et al. (2011) Tripartite motif-containing protein 28 is a small ubiquitin-related 615	
modifier E3 ligase and negative regulator of IFN regulatory factor 7. J Immunol 187:4754-
4763. 
19. Quimby BB, Yong-Gonzalez V, Anan T, Strunnikov AV, Dasso M (2006) The promyelocytic 
leukemia protein stimulates SUMO conjugation in yeast. Oncogene 25:2999-3005. 
20. Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP (2006) The mechanisms of PML-620	
nuclear body formation. Mol Cell 24:331-339. 
21. Peng H, et al. (2007) The structurally disordered KRAB repression domain is incorporated 
into a protease resistant core upon binding to KAP-1-RBCC domain. J Mol Biol 370:269-
289. 
 25 
22. Peng H, et al. (2000) Reconstitution of the KRAB-KAP-1 repressor complex: a model 625	
system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated 
protein-protein interactions. J Mol Biol 295:1139-1162. 
23. Goldstone DC, et al. (2014) Structural studies of postentry restriction factors reveal 
antiparallel dimers that enable avid binding to the HIV-1 capsid lattice. Proc Natl Acad Sci U 
S A 111:9609-9614. 630	
24. Li Y, et al. (2014) Structural insights into the TRIM family of ubiquitin E3 ligases. Cell Res 
24:762-765. 
25. Sanchez JG, et al. (2014) The tripartite motif coiled-coil is an elongated antiparallel hairpin 
dimer. Proc Natl Acad Sci U S A 111:2494-2499. 
26. Koliopoulos MG, et al. (2018) Molecular mechanism of influenza A NS1-mediated TRIM25 635	
recognition and inhibition. Nat Commun 9:1820. 
27. Wang P, et al. (2018) RING tetramerization is required for nuclear body biogenesis and 
PML sumoylation. Nat Commun 9:1277. 
28. Koliopoulos MG, Esposito D, Christodoulou E, Taylor IA, Rittinger K (2016) Functional role 
of TRIM E3 ligase oligomerization and regulation of catalytic activity. EMBO J 35:1204-640	
1218. 
29. Huang SY, et al. (2014) The B-box 1 dimer of human promyelocytic leukemia protein. J 
Biomol NMR 60:275-281. 
30. Yudina Z, et al. (2015) RING Dimerization Links Higher-Order Assembly of TRIM5alpha to 
Synthesis of K63-Linked Polyubiquitin. Cell reports 12:788-797. 645	
31. Dou H, Buetow L, Sibbet GJ, Cameron K, Huang DT (2012) BIRC7-E2 ubiquitin conjugate 
structure reveals the mechanism of ubiquitin transfer by a RING dimer. Nat Struct Mol Biol 
19:876-883. 
32. Dou H, Buetow L, Sibbet GJ, Cameron K, Huang DT (2013) Essentiality of a non-RING 
element in priming donor ubiquitin for catalysis by a monomeric E3. Nat Struct Mol Biol 650	
20:982-986. 
33. Robbez-Masson L, et al. (2018) The HUSH complex cooperates with TRIM28 to repress 
young retrotransposons and new genes. Genome Res 28:836-845. 
34. Sripathy SP, Stevens J, Schultz DC (2006) The KAP1 corepressor functions to coordinate 
the assembly of de novo HP1-demarcated microenvironments of heterochromatin required 655	
for KRAB zinc finger protein-mediated transcriptional repression. Mol Cell Biol 26:8623-
8638. 
 26 
35. Aricescu AR, Lu W, Jones EY (2006) A time- and cost-efficient system for high-level protein 
production in mammalian cells. Acta crystallographica. Section D, Biological crystallography 
62:1243-1250. 660	
36. Schuck P (2003) On the analysis of protein self-association by sedimentation velocity 
analytical ultracentrifugation. Anal Biochem 320:104-124. 
37. Rayment I, et al. (1993) Three-dimensional structure of myosin subfragment-1: a molecular 
motor. Science 261:50-58. 
38. Vonrhein C, et al. (2011) Data processing and analysis with the autoPROC toolbox. Acta 665	
Crystallogr D Biol Crystallogr 67:293-302. 
39. Adams PD, et al. (2010) PHENIX: a comprehensive Python-based system for 
macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213-221. 
40. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta 
Crystallogr D Biol Crystallogr 60:2126-2132. 670	
41. Murshudov GN, et al. (2011) REFMAC5 for the refinement of macromolecular crystal 
structures. Acta Crystallogr D Biol Crystallogr 67:355-367. 
 
